Moderna unseats Novavax at the top. The relentless climb of Moderna has put it at the very top. This weeks out-sized gain on its return -- gaining 240% -- in total return, while Novavax stayed flat with a gain of just 3%, was enough to propel the biggest company in the list to the #1 spot.
BioNTech also had an enormous week, gaining a full 134%.
All others in the top ten gained as well.
The total return of all COVID VACCINE STOCKS is back over the 200% marker: it now sits at 210%. Without Moderna, it would be at 170%.
No comments:
Post a Comment